Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells.

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Biomaterials Science

Background:

• Mesenchymal-like cells derived from human embryonic stem cells (hESC-MCs) hold potential for bone regeneration.
• Current bone tissue engineering often involves pre-differentiation of cells, which may limit their developmental plasticity.

Purpose of the Study:

• To evaluate the in vivo osteogenesis potential of undifferentiated hESC-MCs.
• To assess the capacity of hESC-MCs to form new bone in calvarial defects without prior lineage commitment.

Main Methods:

• Implantation of hESC-MCs on collagen/hydroxyapatite scaffolds into calvarial defects in immunodeficient mice.
• Analysis using X-ray, microCT, and histological examination.
• Verification of human cell contribution using Alu and human mitochondrial antigen staining.

Main Results:

• Consistent formation of highly vascularized new bone bridging the defect and integrating with host bone.
• In situ differentiation of hESC-MCs into hypertrophic chondrocytes, osteoblasts, and osteocytes via endochondral ossification.
• Significant bone formation volume and direct cellular participation exceeding control adult human mesenchymal stem cells (hMSCs).

Conclusions:

• Undifferentiated hESC-MCs possess robust in vivo osteogenesis potential, recapitulating mesenchymal developmental pathways.
• Avoiding pre-implantation differentiation enhances bone regeneration capacity, vascularity, and reproducibility.
• This approach represents a significant advancement for bone tissue engineering, enabling semi-autonomous bone defect repair.